Results of a phase 1B study of recombinant human APO2L/trail with rituximab in patients with relapsed, low-grade NHL

M. Fanale,H. Burris, L. Yee, J. Lucas, K. Dimick, M. Goldwasser, W. Novotny,G. Bray

ANNALS OF ONCOLOGY(2008)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要